Standard BioTools holders approve Treeline merger, reverse split up to 1-for-40, Mass Cytometry sale
#SEC #stocks #investing #LAB #Mergers
🔗 secwatch.observer
Standard BioTools holders approve Treeline merger, reverse split up to 1-for-40, Mass Cytometry sale
#SEC #stocks #investing #LAB #Mergers
🔗 secwatch.observer
https://www.stocktitan.net/news/LAB/standard-bio-tools-stockholders-approve-all-proposals-related-to-kzk4soe3dq6x.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/LAB/standard-bio-tools-stockholders-approve-all-proposals-related-to-kzk4soe3dq6x.html?utm_source=stocktitan-bluesky&utm_medium=social
$LAB · Bad for LAB: Standard BioTools Inc. shared news about a lawsuit connected to its…
RDZN · Good for RDZN: Roadzen Inc. shared its second-quarter results, showing record…
$LAB · Bad for LAB: Standard BioTools Inc. shared news about a lawsuit connected to its…
RDZN · Good for RDZN: Roadzen Inc. shared its second-quarter results, showing record…
• Insider: Thomas D. Carey, Director
• Bought: 75,000 shares (about $47K)
• Price: about $0.63 a share · Nov 5
• Now Holds: 419,456 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: Thomas D. Carey, Director
• Bought: 75,000 shares (about $47K)
• Price: about $0.63 a share · Nov 5
• Now Holds: 419,456 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
On November 3, 2026, Standard BioTools Inc., a Delaware corporation , issued a joint press release with ARCHIMED, a leading investment firm focused exclusively on healthcare industries , announcing the closing of Standard BioTools’ previously announced sale of its Microfluidics business to...
On November 3, 2026, Standard BioTools Inc., a Delaware corporation , issued a joint press release with ARCHIMED, a leading investment firm focused exclusively on healthcare industries , announcing the closing of Standard BioTools’ previously announced sale of its Microfluidics business to...
https://www.stocktitan.net/news/LAB/archimed-life-science-tools-services-completes-acquisition-of-pv2nlvuyy0si.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/LAB/archimed-life-science-tools-services-completes-acquisition-of-pv2nlvuyy0si.html?utm_source=stocktitan-bluesky&utm_medium=social
Learn more: www.artsci.utoronto.ca/news/chemist...
Learn more: www.artsci.utoronto.ca/news/chemist...
I'm thrilled to share that I've started a new chapter in my career at BioTools Co., Ltd. (圖爾思生物科技) as a Sales Specialist in the Industrial Group.
Looking forward to meeting more old friends and new connections in this new journey!
I'm thrilled to share that I've started a new chapter in my career at BioTools Co., Ltd. (圖爾思生物科技) as a Sales Specialist in the Industrial Group.
Looking forward to meeting more old friends and new connections in this new journey!
🔬 Proteomics
🧪 Multiplex ELISA
🧫 Customized Antibody
🧬 Telomere Length Analysis
🧬 Gene & Peptide Synthesis
🧬 RNA Sequencing (RNA-seq)
…and many other customized research services.
🔬 Proteomics
🧪 Multiplex ELISA
🧫 Customized Antibody
🧬 Telomere Length Analysis
🧬 Gene & Peptide Synthesis
🧬 RNA Sequencing (RNA-seq)
…and many other customized research services.
https://www.stocktitan.net/news/LAB/standard-bio-tools-announces-agreement-to-sell-microfluidics-ys6162md3s6n.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/LAB/standard-bio-tools-announces-agreement-to-sell-microfluidics-ys6162md3s6n.html?utm_source=stocktitan-bluesky&utm_medium=social
On October 5, 2026, Standard BioTools Inc., a Delaware corporation , issued a press release announcing that it has entered into a definitive agreement with respect to the sale of its Microfluidics business to ARCHIMED, a leading investment firm focused exclusively on healthcare industries.
On October 5, 2026, Standard BioTools Inc., a Delaware corporation , issued a press release announcing that it has entered into a definitive agreement with respect to the sale of its Microfluidics business to ARCHIMED, a leading investment firm focused exclusively on healthcare industries.
https://www.stocktitan.net/news/LAB/standard-bio-tools-provides-update-on-sale-of-mass-cytometry-kzxcfl76lq6s.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/LAB/standard-bio-tools-provides-update-on-sale-of-mass-cytometry-kzxcfl76lq6s.html?utm_source=stocktitan-bluesky&utm_medium=social
Symfony forms and services for the BioPHP minitools
🔗 https://github.com/amelaye/biotools
Symfony forms and services for the BioPHP minitools
🔗 https://github.com/amelaye/biotools
LAB (Standard BioTools)
Definitive Proxy Filed for $2.5B Reverse Merger with Treeline Biosciences
💰 Current price: $0.7399
Chart reflects closing price
Importance Score: 9/10 | Sentiment: Neutral
Most traders won't see this until tomorrow's headline.
LAB (Standard BioTools)
Definitive Proxy Filed for $2.5B Reverse Merger with Treeline Biosciences
💰 Current price: $0.7399
Chart reflects closing price
Importance Score: 9/10 | Sentiment: Neutral
Most traders won't see this until tomorrow's headline.